Search | IOVS | ARVO Journals

Showing 1 – 20 of 53

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Quantitative metrics in Swept Source-Optical Coherence Tomography in healthy eyes: fractal dimension, an interesting tool?

Louis Arnould; Pierre-Henry GABRIELLE; Florian Baudin; Behzad Aliahmad; Marc Sarossy; Alain M Bron; Catherine P Creuzot Garcher

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2885. doi:

ARVO Annual Meeting Abstract July 2018

Development and validation of a risk-prediction nomogram for poor functional response one year after treatment with anti-VEGF in naive-diabetic macular edema.

Pierre-Henry GABRIELLE; Jacques Bouche-Pillon; Edouard Maupin; Serge Aho-Glele; Ramin Tadayoni; Laurent Kodjikian; Alain M Bron; Pascale Massin; Catherine P Creuzot Garcher

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3615. doi:

ARVO Annual Meeting Abstract June 2017

Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to diabetic macular edema: 12-month results from the 36-month BOREAL-DME study

Catherine P Creuzot Garcher; Pascale Massin; Laurent KODJIKIAN; Jean-Francois Girmens; Cecile DelCourt; Frank Fajnkuchen; Agnès Glacet; Pierre-Jean Guillausseau; Audrey Derveloy; Laetitia FINZI; Patrick Blin; BPE Team

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1915. doi:

ARVO Annual Meeting Abstract June 2017

Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to macular edema secondary to central retinal vein occlusion: 6-month results from the 24-month BOREAL-CRVO study

Mayer Srour; Agnès Glacet; Jean-Francois Girmens; Laurent KODJIKIAN; Cecile DelCourt; Frank Fajnkuchen; Catherine P Creuzot Garcher; Pascale Massin; Pierre-Jean Guillausseau; Anne Ponthieux; Laetitia FINZI; Angela Grelaud-Boussinot; BPE Team

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4630. doi:

ARVO Annual Meeting Abstract June 2017

A Pharmacoepidemiological study of intravitreal drug consumption in the first 12 months of treatment. The EPIdemiology and SAFEty collaboration.

Vincent Daien; Catherine P Creuzot Garcher; Marie-Noëlle Delyfer; Alain M Bron; Mark C Gillies; Sandy Lacombe; Laurence Papinaud; Dominique Cholley; Caroline Domerg; Audrey Cougnard-Gregoire; Catherine Quantin; Max Villain; Jean Pierre Daures; Cecile DelCourt; Jean-Francois Korobelnik

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):902. doi:

ARVO Annual Meeting Abstract June 2017

Role of 24-S-hydroxycholesterol in membrane dynamics during retinal gliosis in glaucoma.

Pierre-Henry GABRIELLE; Ségolène Gambert; Lionel Bretillon; Alain M Bron; Catherine P Creuzot Garcher

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5385. doi:

ARVO Annual Meeting Abstract June 2017

A pro-diabetic diet triggers early functional and structural changes in the rat retina

Elisa Vidal; Elise Lalarme; Laurence Decocq; Marie-Annick Maire; Jeannine Lherminier; Magalie Thierry; Alain M Bron; Catherine P Creuzot Garcher; Niyazi Acar; Lionel Bretillon

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5867. doi:

ARVO Annual Meeting Abstract September 2016

Implication of 24-S-hydroxycholesterol in Müller glial cell’s membrane dynamics in the rat.

Arthur Ferrero; Segolene Gambert-Nicot; NIyazi Acar; Alain M Bron; Lionel Bretillon; Catherine P Garcher

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4198. doi:

ARVO Annual Meeting Abstract September 2016

Impact of a reduction of plasmalogen levels on Müller cell metabolism

Charlotte Pallot; Julie Mazzocco; Stephane Gregoire; Laurent Leclere; Benedicte Buteau; Alain M Bron; Catherine P Garcher; Lionel Bretillon; Niyazi Acar

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4204. doi:

ARVO Annual Meeting Abstract September 2016

Plasmalogens and cell-cell communication between retinal glial cells

Julie Mazzocco; Charlotte Pallot; Benedicte Buteau; Stephane Gregoire; Laurent Leclere; Alain M Bron; Catherine P Garcher; Lionel Bretillon; Niyazi Acar

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4207. doi:

ARVO Annual Meeting Abstract September 2016

Plasma omega 3 polyunsaturated fatty acids and macular pigment optical density in subjects at high risk for age-related macular degeneration: the Limpia Study.

Benedicte MJ Merle; Benjamin Buaud; Jean-Francois Korobelnik; Marie-Noelle Delyfer; Marie B Rougier; Genevieve Chêne; Carole Vaysse; Catherine P Garcher; Cecile DelCourt

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract September 2016

Functional and anatomical outcomes after successful macula-off retinal detachment surgery, a 12 month-follow-up.

Clémence DESCHASSE; Yann Kauffmann; Mathilde Frerot; Alain M Bron; Catherine P Garcher

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1047. doi:

ARVO Annual Meeting Abstract September 2016

Management of diabetic macular edema with visual impairment in real-life practice in France: findings from the cross-sectional BOREAL DME study

Catherine P Garcher; Pascale G Massin; Frank Fajnkuchen; Agnes Glacet-Bernard; Laurent Kodjikian; Jean-François Maher GIRMENS; Cécile Delcourt; Pierre-Jean Guillausseau; Anne Ponthieux

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2086. doi:

ARVO Annual Meeting Abstract September 2016

Ranibizumab in patients with neovascular age-related macular degeneration in real-world clinical settings in France: 1-year data from the LUMINOUS™ study

Vittorio Capuano; OUBRAHAM-MEBROUKINE Hassiba; Benjamin Wolff; Salomon Y Cohen; Catherine P Garcher; Jean-Francois Korobelnik; Ramin Tadayoni; Christian Delhay; Audrey Derveloy; Eric H Souied

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):534. doi:

ARVO Annual Meeting Abstract September 2016

Cholesterol homeostasis and retinal stress in anterior ischemic optic neuropathy

Lionel Bretillon; Cynthia Fourgeux; Jacques Bouche-Pillon; Lucy Martine; Laurent Leclere; Niyazi Acar; Alain M Bron; Catherine P Garcher

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):109. doi:

ARVO Annual Meeting Abstract September 2016

High fat-high fructose diet triggered metabolic syndrome and retinal neovascular complications in the rat

Elisa Vidal; Elise Lalarme; Laurence Decocq; Marie-Annick Maire; Alain M Bron; Catherine P Garcher; Niyazi Acar; Lionel Bretillon

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4528. doi:

ARVO Annual Meeting Abstract September 2016

Gangliosides in the retina: a comparative inventory with brain and other ocular structures

Elodie Masson; Estelle Sibille; Lucy Martine; Olivier Berdeaux; Alain M Bron; Catherine P Garcher; Zhiguo He; Gilles Thuret; Lionel Bretillon

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4812. doi:

ARVO Annual Meeting Abstract September 2016

Anatomical and functional outcomes one year after macular hole surgery.

Louis Arnould; Yann Kauffmann; Abderrahmane Bourredjem; Christine Binquet; Alain M Bron; Catherine P Garcher

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2053. doi:

ARVO Annual Meeting Abstract June 2015

Analysis of the vitreomacular interface in a French population-based study (The MONTRACHET study: Maculopathy, Optic Nerve, nuTRition, neurovAsCular and HEarT diseases)

Jacques Bouche-Pillon; Philippe Koehrer; Alain M Bron; Catherine P Garcher; Christine Binquet; Christophe tzourio; Lionel Bretillon; Niyazi Acar

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1198. doi:

ARVO Annual Meeting Abstract June 2015

The LIMPIA Study: A randomized trial of supplementation with lutein, zeaxanthin, omega 3 fatty acids and antioxidants for increasing macular pigment optical density in high-risk subjects for exudative AMD.

Marie-Noelle Delyfer; Catherine P Garcher; Marie B Rougier; Hélène Savel; Geneviève Chêne; Cecile Delcourt; Jean-Francois Korobelnik

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3784. doi:

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Quantitative metrics in Swept Source-Optical Coherence Tomography in healthy eyes: fractal dimension, an interesting tool?

Development and validation of a risk-prediction nomogram for poor functional response one year after treatment with anti-VEGF in naive-diabetic macular edema.

Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to diabetic macular edema: 12-month results from the 36-month BOREAL-DME study

Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to macular edema secondary to central retinal vein occlusion: 6-month results from the 24-month BOREAL-CRVO study

A Pharmacoepidemiological study of intravitreal drug consumption in the first 12 months of treatment. The EPIdemiology and SAFEty collaboration.

Role of 24-S-hydroxycholesterol in membrane dynamics during retinal gliosis in glaucoma.

A pro-diabetic diet triggers early functional and structural changes in the rat retina

Implication of 24-S-hydroxycholesterol in Müller glial cell’s membrane dynamics in the rat.

Impact of a reduction of plasmalogen levels on Müller cell metabolism

Plasmalogens and cell-cell communication between retinal glial cells

Plasma omega 3 polyunsaturated fatty acids and macular pigment optical density in subjects at high risk for age-related macular degeneration: the Limpia Study.

Functional and anatomical outcomes after successful macula-off retinal detachment surgery, a 12 month-follow-up.

Management of diabetic macular edema with visual impairment in real-life practice in France: findings from the cross-sectional BOREAL DME study

Ranibizumab in patients with neovascular age-related macular degeneration in real-world clinical settings in France: 1-year data from the LUMINOUS™ study

Cholesterol homeostasis and retinal stress in anterior ischemic optic neuropathy

High fat-high fructose diet triggered metabolic syndrome and retinal neovascular complications in the rat

Gangliosides in the retina: a comparative inventory with brain and other ocular structures

Anatomical and functional outcomes one year after macular hole surgery.

Analysis of the vitreomacular interface in a French population-based study (The MONTRACHET study: Maculopathy, Optic Nerve, nuTRition, neurovAsCular and HEarT diseases)

The LIMPIA Study: A randomized trial of supplementation with lutein, zeaxanthin, omega 3 fatty acids and antioxidants for increasing macular pigment optical density in high-risk subjects for exudative AMD.

To View More...

You must be signed into an individual account to use this feature.